Genesis Growth Tech Acquisition Corp.
NeuroMind AI Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus its efforts on identifying technology companies operating primarily within the consumer internet industry in Europe, Israel, the United Ara… Read more
Genesis Growth Tech Acquisition Corp. (GGAUF) - Net Assets
Latest net assets as of March 2024: $-4.56 Million USD
Based on the latest financial reports, Genesis Growth Tech Acquisition Corp. (GGAUF) has net assets worth $-4.56 Million USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.06 Million) and total liabilities ($5.62 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-4.56 Million |
| % of Total Assets | -429.09% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 50.94 |
Genesis Growth Tech Acquisition Corp. - Net Assets Trend (2021–2023)
This chart illustrates how Genesis Growth Tech Acquisition Corp.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Genesis Growth Tech Acquisition Corp. (2021–2023)
The table below shows the annual net assets of Genesis Growth Tech Acquisition Corp. from 2021 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-4.29 Million | -101.75% |
| 2022-12-31 | $244.95 Million | +0.14% |
| 2021-12-31 | $244.61 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Genesis Growth Tech Acquisition Corp.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 694862500.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $949.22K | % |
| Total Equity | $-4.29 Million | 100.00% |
Genesis Growth Tech Acquisition Corp. Competitors by Market Cap
The table below lists competitors of Genesis Growth Tech Acquisition Corp. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Az Quest Infra-Yield Ii Fundo De Investimento Em Participacoes Em Infraestrutura
SA:AZIN11
|
$159.62K |
|
COMPASS MINERALS
BE:CM8
|
$159.74K |
|
Petron Corp Preferred Series 4E
PSE:PRF4E
|
$159.82K |
|
DHCNI
NASDAQ:DHCNI
|
$159.86K |
|
CHINA GOLD INTL
BE:JI3
|
$159.56K |
|
PGIM Short Duration High Yield Opportunities Fund
NYSE:SDHY
|
$159.45K |
|
CENT.+EAST.EUR.FD DL-001
F:EEE
|
$159.28K |
|
BankFLORIDA Bancorp Inc.
OTCQX:BKFL
|
$158.82K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Genesis Growth Tech Acquisition Corp.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 244,945,237 to -4,290,429, a change of -249,235,666 (-101.8%).
- Net income of 421,353 contributed positively to equity growth.
- Share repurchases of 263,572,019 reduced equity.
- Other factors increased equity by 13,915,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $421.35K | +9.82% |
| Share Repurchases | $263.57 Million | -6143.26% |
| Other Changes | $13.91 Million | +324.33% |
| Total Change | $- | -101.75% |
Book Value vs Market Value Analysis
This analysis compares Genesis Growth Tech Acquisition Corp.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $42391.05 | $11.71 | x |
| 2022-12-31 | $7745.30 | $11.71 | x |
| 2023-12-31 | $-0.42 | $11.71 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Genesis Growth Tech Acquisition Corp. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.03%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -0.04% | 0.00% | 0.00x | 1.06x | $-24.57 Million |
| 2022 | 0.14% | 0.00% | 0.00x | 1.08x | $-24.16 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $850.40K |
Industry Comparison
This section compares Genesis Growth Tech Acquisition Corp.'s net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Genesis Growth Tech Acquisition Corp. (GGAUF) | $-4.56 Million | -0.04% | N/A | $159.58K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |